Globus Medical, Inc. (GMED) — Analyst outlook / Analyst consensus target is. Based on 36 analyst ratings, the consensus is bullish — 27 Buy, 8 Hold, 1 Sell.
The consensus price target is $104.00 (low: $64.00, high: $115.00), representing an upside of 9.5% from the current price $94.94.
Analysts estimate Earnings Per Share (EPS) of $2.99 and revenue of $2.51B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $0.76 vs est $2.99 (missed -74.6%). 2025: actual $3.98 vs est $3.85 (beat +3.3%). Analyst accuracy: 0%.
GMED Stock — 12-Month Price Forecast
$104.00
▲ +9.54% Upside
Average Price Target
Based on 36 Wall Street analysts offering 12-month price targets for Globus Medical, Inc., the average price target is $104.00, with a high forecast of $115.00, and a low forecast of $64.00.
The average price target represents a +9.54% change from the last price of $94.94.
Highest Price Target
$115.00
Average Price Target
$104.00
Lowest Price Target
$64.00
GMED Analyst Ratings
Buy
Based on 36 analysts giving stock ratings to Globus Medical, Inc. in the past 3 months
EPS Estimates — GMED
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.76
vs Est $2.99
▼ 293.2% off
2025
Actual $3.98
vs Est $3.85
▲ 3.2% off
Profitability Outlook
Company is profitable with solid earnings. EPS trend is improving.
Revenue Estimates — GMED
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $2.519B
vs Est $2.507B
▲ 0.5% off
2025
Actual $2.939B
vs Est $2.912B
▲ 0.9% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
